# Bitmine Immersion Technologies, Inc.: financial statements, quarterly

BMNR · NYSE · CIK 1829311 · [Financials](/sectors/financials.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/bmnr.md) · [Financials](/companies/bmnr/financials.md) · [Filings](/companies/bmnr/filings.md) · [Insiders](/companies/bmnr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bmnr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.2 d](/filings/0001683168-25-002276.md) | [0.5](/filings/0001683168-25-000223.md) | [0.9](/filings/0001683168-25-002541.md) | [1.2](/filings/0001683168-25-004889.md) | [0.7 d](/filings/0001493152-25-024679.md) | [1.2](/filings/0001493152-26-002084.md) | [1.5](/filings/0001493152-26-016560.md) | [2.1](/filings/0001628280-26-048157.md) | [1.3 d](/filings/0001493152-25-024679.md) | [2.3](/filings/0001493152-26-002084.md) | [11.0](/filings/0001493152-26-016560.md) | [46.5](/filings/0001628280-26-048157.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | [1.2](/filings/0001493152-26-002084.md) | [1.4](/filings/0001493152-26-016560.md) | [1.7](/filings/0001628280-26-048157.md) | [1.4 d](/filings/0001493152-25-024679.md) | [1.0](/filings/0001493152-26-002084.md) | [1.4](/filings/0001493152-26-016560.md) | [5.7](/filings/0001628280-26-048157.md) |
| Gross profit | $m | [0.1 d](/filings/0001683168-25-002276.md) | [0.1](/filings/0001683168-25-000223.md) | [0.3](/filings/0001683168-25-002541.md) | [0.2](/filings/0001683168-25-004889.md) | [0.1 d](/filings/0001683168-25-002276.md) | [0.1](/filings/0001683168-25-000223.md) | [0.3](/filings/0001683168-25-002541.md) | [0.5](/filings/0001683168-25-004889.md) | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.1) d](/filings/0001683168-25-002276.md) | [(0.6)](/filings/0001683168-25-000223.md) | [(0.6)](/filings/0001683168-25-002541.md) | [(0.5)](/filings/0001683168-25-004889.md) | [(0.7) d](/filings/0001493152-25-024679.md) | [(0.9)](/filings/0001493152-26-002084.md) | [(0.9)](/filings/0001493152-26-016560.md) | [(0.5)](/filings/0001628280-26-048157.md) | [446 d](/filings/0001493152-25-024679.md) | [(5,470)](/filings/0001493152-26-002084.md) | [(3,841)](/filings/0001493152-26-016560.md) | [(11.9)](/filings/0001628280-26-048157.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.1](/filings/0001683168-24-004815.md) | [0.1 d](/filings/0001493152-25-024679.md) | [0.1](/filings/0001493152-26-002084.md) | [0.1](/filings/0001493152-26-016560.md) | not reported | not reported | [0.2](/filings/0001493152-26-002084.md) | [(4.8)](/filings/0001493152-26-016560.md) | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-048157.md) | [92.3 d](/filings/0001493152-25-024679.md) | [(92.3)](/filings/0001493152-26-002084.md) | [0.0 d](/filings/0001493152-26-016560.md) | [0.0](/filings/0001628280-26-048157.md) |
| Net income | $m | [(1.2) d](/filings/0001683168-25-002276.md) | [(0.9)](/filings/0001683168-25-004889.md) | [(0.9)](/filings/0001683168-25-004889.md) | [(0.7)](/filings/0001683168-25-004889.md) | [(0.8) d](/filings/0001493152-25-024679.md) | [(1.0)](/filings/0001493152-26-016560.md) | [(1.2)](/filings/0001493152-26-016560.md) | [(0.6)](/filings/0001683168-25-004889.md) | [351 d](/filings/0001493152-25-024679.md) | [(5,204)](/filings/0001493152-26-016560.md) | [(3,818)](/filings/0001493152-26-016560.md) | [(83.6)](/filings/0001628280-26-048157.md) |
| Diluted EPS | $ per share | not reported | [(0.02)](/filings/0001683168-25-000223.md) | [(0.02)](/filings/0001683168-25-002541.md) | [(0.26)](/filings/0001683168-25-004889.md) | not reported | [(1.66)](/filings/0001493152-26-002084.md) | [(0.58)](/filings/0001493152-26-016560.md) | [(0.31)](/filings/0001628280-26-048157.md) | not reported | [(15.98)](/filings/0001493152-26-002084.md) | [(8.40)](/filings/0001493152-26-016560.md) | [(0.15)](/filings/0001628280-26-048157.md) |
| Basic EPS | $ per share | not reported | [(0.02)](/filings/0001683168-25-000223.md) | [(0.02)](/filings/0001683168-25-002541.md) | [(0.26)](/filings/0001683168-25-004889.md) | not reported | [(1.66)](/filings/0001493152-26-002084.md) | [(0.58)](/filings/0001493152-26-016560.md) | [(0.31)](/filings/0001628280-26-048157.md) | not reported | [(15.98)](/filings/0001493152-26-002084.md) | [(8.40)](/filings/0001493152-26-016560.md) | [(0.15)](/filings/0001628280-26-048157.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | period not labelled (2024-11-01) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-29) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001683168-24-000250.md) | not reported | not reported | [0.0](/filings/0001493152-25-024679.md) | [0.0](/filings/0001493152-25-024679.md) | [0.0](/filings/0001683168-25-000223.md) | [0.0](/filings/0001683168-25-002541.md) | [0.0](/filings/0001683168-25-004889.md) | [0.0](/filings/0001493152-25-024679.md) | [0.9](/filings/0001493152-26-002084.md) | [0.9](/filings/0001493152-26-016560.md) | [0.3](/filings/0001628280-26-048157.md) |
| Current assets | $bn | [0.0](/filings/0001683168-24-000250.md) | [0.0](/filings/0001683168-24-002367.md) | [0.0](/filings/0001683168-24-004815.md) | [0.0](/filings/0001493152-25-024679.md) | not reported | [0.0](/filings/0001683168-25-000223.md) | [0.0](/filings/0001683168-25-002541.md) | [0.0](/filings/0001683168-25-004889.md) | [0.5](/filings/0001628280-26-048157.md) | [0.9](/filings/0001493152-26-002084.md) | [0.9](/filings/0001493152-26-016560.md) | [0.4](/filings/0001628280-26-048157.md) |
| Total assets | $bn | [0.0](/filings/0001683168-24-000250.md) | [0.0](/filings/0001683168-24-002367.md) | [0.0](/filings/0001683168-24-004815.md) | [0.0](/filings/0001493152-25-024679.md) | not reported | [0.0](/filings/0001683168-25-000223.md) | [0.0](/filings/0001683168-25-002541.md) | [0.0](/filings/0001683168-25-004889.md) | [8.8](/filings/0001628280-26-048157.md) | [11.5](/filings/0001493152-26-002084.md) | [9.9](/filings/0001493152-26-016560.md) | [11.6](/filings/0001628280-26-048157.md) |
| Current liabilities | $bn | [0.0](/filings/0001683168-24-000250.md) | [0.0](/filings/0001683168-24-002367.md) | [0.0](/filings/0001683168-24-004815.md) | [0.0](/filings/0001493152-25-024679.md) | not reported | [0.0](/filings/0001683168-25-000223.md) | [0.0](/filings/0001683168-25-002541.md) | [0.0](/filings/0001683168-25-004889.md) | [0.0](/filings/0001628280-26-048157.md) | [0.1](/filings/0001493152-26-002084.md) | [0.0](/filings/0001493152-26-016560.md) | [0.0](/filings/0001628280-26-048157.md) |
| Total liabilities | $bn | [0.0](/filings/0001683168-24-000250.md) | [0.0](/filings/0001683168-24-002367.md) | [0.0](/filings/0001683168-24-004815.md) | [0.0](/filings/0001493152-25-024679.md) | not reported | [0.0](/filings/0001683168-25-000223.md) | [0.0](/filings/0001683168-25-002541.md) | [0.0](/filings/0001683168-25-004889.md) | [0.1](/filings/0001628280-26-048157.md) | [0.2](/filings/0001493152-26-002084.md) | [0.0](/filings/0001493152-26-016560.md) | [0.0](/filings/0001628280-26-048157.md) |
| Shareholders' equity | $bn | [0.0](/filings/0001683168-25-004889.md) | [0.0](/filings/0001683168-25-004889.md) | [0.0](/filings/0001683168-25-004889.md) | [0.0](/filings/0001493152-26-016560.md) | not reported | [0.0](/filings/0001493152-26-016560.md) | [0.0](/filings/0001493152-26-016560.md) | [0.0](/filings/0001683168-25-004889.md) | [8.7](/filings/0001628280-26-048157.md) | [11.3](/filings/0001493152-26-016560.md) | [9.9](/filings/0001493152-26-016560.md) | [11.6](/filings/0001628280-26-048157.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.4) d](/filings/0001683168-25-002276.md) | [(0.0)](/filings/0001683168-25-000223.md) | [(0.2) d](/filings/0001683168-25-002541.md) | [(0.0) d](/filings/0001683168-25-004889.md) | [0.2 d](/filings/0001493152-25-024679.md) | [(0.1)](/filings/0001493152-26-002084.md) | [(0.2) d](/filings/0001493152-26-016560.md) | [1.7 d](/filings/0001628280-26-048157.md) | [(5.5) d](/filings/0001493152-25-024679.md) | [(228)](/filings/0001493152-26-002084.md) | [(88.2) d](/filings/0001493152-26-016560.md) | [29.0 d](/filings/0001628280-26-048157.md) |
| Capital expenditure | $m | [(0.1) d](/filings/0001683168-25-002276.md) | [0.1](/filings/0001683168-25-000223.md) | [(0.0) d](/filings/0001683168-25-002541.md) | [0.0 d](/filings/0001683168-25-004889.md) | [0.0 d](/filings/0001493152-25-024679.md) | [0.0](/filings/0001493152-26-002084.md) | [0.0 d](/filings/0001493152-26-016560.md) | [0.0 d](/filings/0001628280-26-048157.md) | [1.0 d](/filings/0001493152-25-024679.md) | [0.4](/filings/0001493152-26-002084.md) | [0.0 d](/filings/0001493152-26-016560.md) | [0.0 d](/filings/0001628280-26-048157.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.7](/filings/0001683168-24-000250.md) | [48.8](/filings/0001683168-24-002367.md) | [48.9](/filings/0001683168-24-004815.md) | [49.7](/filings/0001683168-25-000223.md) | [49.7](/filings/0001683168-25-002541.md) | [2.5](/filings/0001683168-25-004889.md) | [2.4](/filings/0001493152-26-002084.md) | [2.0](/filings/0001493152-26-016560.md) | [2.0](/filings/0001628280-26-048157.md) | [326](/filings/0001493152-26-002084.md) | [455](/filings/0001493152-26-016560.md) | [552](/filings/0001628280-26-048157.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 603,226,394 at 2026-07-09, from the cover of the [10-Q filed 2026-07-14](/filings/0001628280-26-048157.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.